NURS FPX 9030 Assessment 1 Raw Data Upload

NURS FPX 9030 Assessment 1 Raw Data Upload

Student Name

University

NURS-FPX9030: Doctor of Nursing Practice Across the Lifespan III
Dr.

July, 2026

Raw Data Upload

Despite this, diabetes remains a key chronic disease in primary care that requires continuous monitoring, structured pathways to follow, and patient education, tailored to each patient, to reduce complications and the burden of the disease. As part of the project site, a high proportion of diabetic adults (42%) have HbA1c levels above 9%, indicating a need for improvement with respect to continuing care, health education distribution, and consistency of follow-up. The PICOT question for the quality improvement project is: How can the implementation of the ADA diabetes follow-up protocol (I) in the nursing staff’s care of adults with diabetes (P), compared to the current approach to diabetes care (C), affect glycemic control (O) over the next eight weeks (T)? The project team suggests a follow-up plan based on the existing evidence to ensure staff competency and better glycemic outcomes, to highlight the need for structured, collaborative, and sustainable diabetes care practice.
The raw data collected during an implementation of an 8-week quality improvement (QI) project to improve glycemic control in adults with type 2-diabetes (T2DM) in an outpatient primary care clinic is presented below. The project team used the diabetes follow-up plan outlined by the American Diabetes Association (ADA) and looked at the results of the project on patient glucose outcomes, staff clinical competency, patient follow-up adherence, and self-management behaviors. The following data are all anonymous. Instead of the patient’s name, participant IDs (P001 – P020) were utilized. Staff IDs (S001–S008) were used in place of staff names. However, no personally identifiable information (PII) is provided. Information was collected from the clinics’ electronic health record (EHR) system and competency items completed throughout the implementation period.

Table 1

Patient Demographic Characteristics and Baseline HbA1c (N = 20)

Participant ID	Age Group	Sex	Race/Ethnicity	Insurance Type	T2DM Duration (yrs)	Baseline HbA1c (%)
P001	45–54	Female	Hispanic/Latino	Medicaid	6	9.8
P002	55–64	Male	Black/African American	Medicare	11	10.2
P003	35–44	Female	White/Non-Hispanic	Private	3	8.7
P004	55–64	Female	Hispanic/Latino	Medicaid	9	11.1
P005	45–54	Male	Asian	Medicaid	5	9.4
P006	65+	Male	Black/African American	Medicare	14	10.8
P007	35–44	Female	White/Non-Hispanic	Private	2	8.3
P008	55–64	Male	Hispanic/Latino	Medicaid	8	9.9
P009	45–54	Female	Asian	Private	4	8.9
P010	65+	Female	Black/African American	Medicare	16	11.4
P011	35–44	Male	White/Non-Hispanic	Private	3	8.5
P012	55–64	Female	Hispanic/Latino	Medicaid	10	10.6
P013	45–54	Male	Black/African American	Medicaid	7	9.7
P014	65+	Female	Hispanic/Latino	Medicare	13	10.9
P015	35–44	Male	Asian	Private	2	8.2
P016	55–64	Female	White/Non-Hispanic	Private	9	9.3
P017	45–54	Male	Hispanic/Latino	Medicaid	6	10.1
P018	65+	Female	Black/African American	Medicare	18	11.7
P019	35–44	Female	Asian	Private	1	7.8
P020	55–64	Male	White/Non-Hispanic	Private	11	9.6

Note. All patient identifiers have been replaced with study codes. Age group, sex, race/ethnicity, and insurance type were self-reported. T2DM duration and baseline HbA1c were extracted from EHR records at Week 1. T2DM = type 2 diabetes mellitus; HbA1c = hemoglobin A1c.

Table 2

Patient HbA1c Outcomes Across Measurement Time Points (N = 20)

Participant ID	Baseline HbA1c (%)	Week 4 HbA1c (%)	Week 8 HbA1c (%)	Change (Baseline to Wk 8)	Target Met (<7%)
P001	9.8	9.1	8.4	−1.4	No
P002	10.2	9.6	8.8	−1.4	No
P003	8.7	8.1	7.4	−1.3	No
P004	11.1	10.3	9.2	−1.9	No
P005	9.4	8.7	7.9	−1.5	No
P006	10.8	10.0	9.1	−1.7	No
P007	8.3	7.6	7.0	−1.3	No
P008	9.9	9.2	8.3	−1.6	No
P009	8.9	8.3	7.5	−1.4	No
P010	11.4	10.7	9.6	−1.8	No
P011	8.5	7.9	7.1	−1.4	No
P012	10.6	9.8	8.9	−1.7	No
P013	9.7	9.0	8.2	−1.5	No
P014	10.9	10.2	9.3	−1.6	No
P015	8.2	7.5	6.9	−1.3	Yes
P016	9.3	8.6	7.8	−1.5	No
P017	10.1	9.4	8.5	−1.6	No
P018	11.7	10.9	9.8	−1.9	No
P019	7.8	7.2	6.7	−1.1	Yes
P020	9.6	8.9	8.0	−1.6	No

Note. HbA1c values (%) were obtained from laboratory results integrated into the clinic EHR at Baseline (Week 1), Week 4, and Week 8. Change score reflects Week 8 HbA1c minus Baseline HbA1c. Target achievement was defined as HbA1c < 7% per ADA Standards of Care. HbA1c = hemoglobin A1c; ADA = American Diabetes Association.

Table 3

Patient Follow-Up Adherence and Visit Completion Data (N = 20)

Participant ID	Scheduled Visits (n = 6)	Completed Visits (n)	Missed Visits (n)	Telehealth Visits Used	Completion Rate (%)
P001	6	6	0	1	100
P002	6	5	1	0	83
P003	6	6	0	2	100
P004	6	4	2	1	67
P005	6	6	0	0	100
P006	6	5	1	2	83
P007	6	6	0	1	100
P008	6	6	0	0	100
P009	6	5	1	1	83
P010	6	4	2	2	67
P011	6	6	0	0	100
P012	6	6	0	1	100
P013	6	5	1	0	83
P014	6	6	0	2	100
P015	6	6	0	0	100
P016	6	5	1	1	83
P017	6	6	0	1	100
P018	6	4	2	2	67
P019	6	6	0	0	100
P020	6	5	1	1	83

Note. Biweekly follow-up visits were scheduled over the 8-week implementation period (6 visits per patient). Telehealth visits were offered to patients with mobility or transportation barriers. Completion rate = (completed visits / 6) x 100.

Table 4

Nursing Staff Competency Assessment Results (N = 8)

Staff ID	Role	Pre-Training Score (/100)	Post-Training Score (/100)	Score Change	Threshold Met (≥80%)	Checklist Completion (%)
S001	Nurse Practitioner	62	88	+26	Yes	95
S002	Nurse Practitioner	58	84	+26	Yes	92
S003	Nurse Practitioner	65	91	+26	Yes	98
S004	Medical Assistant	50	78	+28	No	85
S005	Medical Assistant	55	83	+28	Yes	88
S006	Care Coordinator	60	86	+26	Yes	94
S007	Health Educator	70	93	+23	Yes	97
S008	Medical Assistant	52	80	+28	Yes	89

Note. The diabetes management competency assessment instrument was validated and administered at Week 1 and Week 8, with pre-training scores and post-training scores obtained. The pre-defined competency success criterion for this competency was 80% or higher. Checklist completion indicates the percentage of randomly audited patient visits documented completely and accurately.

Table 5

Patient Self-Management Behavior Checklist — Week 8 (N = 20)

Participant ID	Blood Glucose Monitoring (Daily)	Medication Adherence (Self-Report)	Diet/Nutrition Log Completed	Physical Activity Goal Met	Engagement Score (/10)
P001	Yes	Yes	Yes	Partial	8
P002	Partial	Yes	No	No	5
P003	Yes	Yes	Yes	Yes	9
P004	No	Partial	No	No	4
P005	Yes	Yes	Yes	Yes	10
P006	Partial	Yes	Yes	Partial	7
P007	Yes	Yes	Yes	Yes	10
P008	Yes	Yes	Partial	Yes	8
P009	Yes	Yes	Yes	Partial	8
P010	No	Partial	No	No	3
P011	Yes	Yes	Yes	Yes	9
P012	Yes	Yes	Yes	Partial	8
P013	Partial	Yes	Partial	Yes	7
P014	Partial	Yes	Yes	Partial	7
P015	Yes	Yes	Yes	Yes	10
P016	Yes	Yes	Yes	Yes	9
P017	Partial	Partial	Yes	No	6
P018	No	Partial	No	No	3
P019	Yes	Yes	Yes	Yes	10
P020	Yes	Yes	Yes	Partial	8

Note. Patients reported their own self-management behavior at an 8-week post-visit using the standardized self-management checklist. Nursing staff assigned an engagement score, ranging from 0 to 10, based on patient participation, responsiveness, and adherence during the 8 weeks. Partial = behavior was occasionally done, but not always.

Table 6

Summary Statistics: Project Implementation Outcomes

Metric	Value
Total patients enrolled (N)	20
Mean baseline HbA1c (%)	9.95
Mean Week 8 HbA1c (%)	8.22
Mean HbA1c reduction	−1.52%
Patients achieving HbA1c < 7% at Week 8, n (%)	2 (10%)
Overall follow-up completion rate	89.2%
Staff achieving >= 80% competency threshold, n (%)	7 (87.5%)
Mean staff pre-training score	59.0
Mean staff post-training score	85.4
Patients reporting full medication adherence, n (%)	14 (70%)
Patients with complete blood glucose monitoring, n (%)	13 (65%)

Note. Summary statistics were calculated from EHR data, competency assessments, and patient self-management checklists collected across the 8-week implementation period. HbA1c = hemoglobin A1c; T2DM = type 2 diabetes mellitus.

Data Collection Notes

Structured EHR queries, standardized competency assessment, and patient self-management checklist was used for prospective data collection at two measurement points: baseline (Week 1) and post-intervention (Week 8). Only 67% (3 patients) attended 6 visits. These patients had transportation barriers, and they were allowed to be connected via telehealth, but opted out, or connectivity was a problem. The HbA1c data were available at all three time points via in-person visits. All patient records (n = 20) were reviewed for documentation consistency. One staff member (S004) did not achieve the≥80% threshold after the post-training and was offered remedial coaching, and a follow-up assessment was planned. The data in this report have been anonymized as required by HIPAA. Patient names and medical record numbers are not stored on unencrypted patient devices, but are kept on clinic servers that are only accessible by the project team and preceptor and password-protected.

References

References for the Assessment 1 will be uploaded soon. Please check back at a later time.

NURS FPX 9030 Assessment 1 Raw Data Upload

Raw Data Upload

Table 1

Table 2

Table 3

Table 4

Table 5

Table 6

Data Collection Notes

References

Related Posts